Mentice AB 

SEK13.3
0
+SEK0.45+3.5% Friday 10:58

Statistics

Day High
13.3
Day Low
12.9
52W High
15.2
52W Low
12.85
Volume
260
Avg. Volume
1,778
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

29JanExpected
Q2 2025
Q3 2025
Q4 2025
-0.2
-0.14
-0.09
-0.03
Expected EPS
-0.029561483370426005
Actual EPS
N/A

Financials

1.31%Profit Margin
Profitable
2014
2015
3.74BRevenue
49.09MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MNTC-BTA.ST. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Intuitive Surgical
ISRG
Mkt Cap160.56B
Intuitive Surgical produces robotic surgical systems, competing in the high-tech medical device market similar to Mentice's simulation technology.
Medtronic
MDT
Mkt Cap111.22B
Medtronic offers medical technologies, services, and solutions, including surgical simulation, directly competing with Mentice's offerings.
Smith & Nephew
SNN
Mkt Cap13.72B
Smith & Nephew specializes in surgical devices and advanced wound management, which overlaps with Mentice's surgical training technologies.
Stryker
SYK
Mkt Cap126.97B
Stryker manufactures medical and surgical equipment, including simulation and training tools, competing in the same space as Mentice.
Zimmer Biomet
ZBH
Mkt Cap18.01B
Zimmer Biomet specializes in musculoskeletal healthcare, including surgical solutions that compete with Mentice's simulation products.
Globus Medical
GMED
Mkt Cap11.89B
Globus Medical develops musculoskeletal solutions, including surgical simulators, which are in direct competition with Mentice's products.
Resmed
RMD
Mkt Cap32.71B
ResMed specializes in cloud-connected medical devices for sleep apnea, COPD, and other chronic diseases, indirectly competing in the broader medical tech field.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific produces medical devices used in various interventions, including endoscopy and urology, competing with Mentice's interventional simulation tech.
ICU Medical
ICUI
Mkt Cap3.04B
ICU Medical provides infusion therapy and related services, competing indirectly by offering high-tech solutions in patient care and training.

About

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; patient simulator accessories and extensions for endovascular therapies; and Angiosuite integrations, such as the VIST virtual patient and Laerdal SimMan vascular medical simulator. It also provides flow model products, which include physiological flow systems, silicone and 3D printed vessels, and flow system accessories; Ankyras, a clinical decision application; Mentice Live, a cloud-based learning center for medical technology industry and healthcare providers; Mentice Right Heart Cath app, a mobile solution for interactive real-time exploration into the right heart catheterization procedure; Vascular Twin, an anatomical replication for procedural and device adoption; research and development services; and professional support services for installation, training, and warranty services. It operates in Europe, the Middle East, Africa, the Asia Pacific, and the Americas. Mentice AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden.
Show more...
CEO
Mr. Frans Matthieu Venker
Employees
124
Country
United States
ISIN
SE0025667389

Listings

0 Comments

Share your thoughts

FAQ

What is Mentice AB stock price today?
The current price of MNTC-BTA.ST is SEK13.3 SEK — it has increased by +3.5% in the past 24 hours. Watch Mentice AB stock price performance more closely on the chart.
What is Mentice AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Mentice AB stocks are traded under the ticker MNTC-BTA.ST.
What is Mentice AB revenue for the last year?
Mentice AB revenue for the last year amounts to 3.74B SEK.
What is Mentice AB net income for the last year?
MNTC-BTA.ST net income for the last year is 49.09M SEK.
How many employees does Mentice AB have?
As of April 12, 2026, the company has 124 employees.
In which sector is Mentice AB located?
Mentice AB operates in the Health & Wellness sector.
When did Mentice AB complete a stock split?
Mentice AB has not had any recent stock splits.
Where is Mentice AB headquartered?
Mentice AB is headquartered in Gothenburg, United States.